| abstract |
This invention relates to an improved female birth control method which substantially reduces breakthrough bleeding and mood or emotional disorders in women, and more particularly, to a contraceptive unit comprising at least one aromatase inhibitor combined with a combination of a substance exhibiting estrogen activity, or a substance exhibiting progestin activity, or both substances in amounts required to prevent pregnancy in females. |